Drugs / BI 1005273
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01650155 | Jul 2012 → Sep 2014 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BI 1005273 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01650155 ↗ |
| Route | Subcutaneous | “subcutaneous injection” NCT01650155 ↗ |